Healthcare -
Biotechnology - NASDAQ - US
$ 3.485
1.01 %
$ 660 M
Market Cap
-8.1
P/E
ABUS - REVENUE
Revenue ABUS - Arbutus Biopharma Corporation
18.1 M
LAST VALUE
28.49%
2 YEAR CAGR
25.19%
5 YEAR CAGR
1.61%
10 YEAR CAGR